CVE-2026-21923
- State
- Published
- Severity
- 6.5 Medium
- Published
- Jan 20, 2026
- Updated
- Jan 21, 2026
- Reserved
- Jan 5, 2026
Description
Vulnerability in the Oracle Life Sciences Central Designer product of Oracle Health Sciences Applications (component: Platform). The supported version that is affected is 7.0.1.0. Easily exploitable vulnerability allows unauthenticated attacker with network access via HTTP to compromise Oracle Life Sciences Central Designer. Successful attacks of this vulnerability can result in unauthorized update, insert or delete access to some of Oracle Life Sciences Central Designer accessible data as well as unauthorized read access to a subset of Oracle Life Sciences Central Designer accessible data. CVSS 3.1 Base Score 6.5 (Confidentiality and Integrity impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:N).
Scores
| CVSS | Score | Vector | Source |
|---|---|---|---|
| 3.1 | 6.5 Medium | CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:N | oracle |
Weaknesses
The record names no weakness.
Affected Products
| Product | Versions |
|---|---|
Oracle Life Sciences Central DesignerOracle Corporation |
|
References
- Oracle Advisoryvendor-advisory
Every record here comes from the CVE Program’s CVE List. © 1999–2026 The MITRE Corporation. CVE is a registered trademark of The MITRE Corporation. The records are reproduced under the CVE Program terms of use.